Study type: Human research · Status: Verified against declared source

Cerebrolysin and repetitive transcranial magnetic stimulation (rTMS) in patients with traumatic brain injury: a three-arm randomized trial

2023

Study scale: The findings of this study suggest that rTMS and Cerebrolysin may be effective interventions for improving cognitive and functional outcomes in TBI patients.

Abstract only: Open source record

Product or molecular entity relationships

Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

We hypothesized that one potential approach to improve outcomes in traumatic brain injury (TBI) patients is combining Cerebrolysin treatment with repetitive transcranial magnetic stimulation (rTMS).

Methods

This trial evaluated the safety and efficacy of combining Cerebrolysin treatment with repetitive transcranial magnetic stimulation (rTMS) for patients with traumatic brain injury (TBI).

Scale or participants

The findings of this study suggest that rTMS and Cerebrolysin may be effective interventions for improving cognitive and functional outcomes in TBI patients.

Key findings

Traumatic brain injury (TBI) is a major public health problem affecting millions worldwide.

Limitations and uncertainty

The findings of this study suggest that rTMS and Cerebrolysin may be effective interventions for improving cognitive and functional outcomes in TBI patients.

Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.